Ignite Creation Date:
2024-05-05 @ 5:20 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00438178
Status:
COMPLETED
Last Update Posted:
2014-05-12
First Post:
2007-02-21
Brief Title:
Safety and Efficacy of Obatoclax Mesylate GX15-070MS for the Treatment of Hematological Malignancies
Sponsor:
Gemin X
Organization:
Teva Branded Pharmaceutical Products RD Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-10
Start Date Type:
None
Primary Completion Date:
2007-10
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2007-02-21
First Submit QC Date:
February 21 2007
Study First Post Date:
2007-02-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-05-09
Last Update Post Date:
2014-05-12
Last Update Post Date Type:
ESTIMATED